熱門資訊> 正文
Runway Growth Finance将收购SWK
2025-10-10 05:59
- Runway Growth Finance (NASDAQ:RWAY) announced on Thursday that it has entered into a definitive merger agreement to acquire SWK (NASDAQ:SWKH), a life science focused finance company that provides minimally dilutive financing to small- and mid-sized commercial-stage healthcare companies.
- The transaction will be a net asset value (NAV) merger and will have an estimated purchase price of approximately $220 million, based on SWK’s June 30, 2025, reported financials and including estimated SWK transaction expenses.
- The transaction includes a fixed stock component expected to total $75.5 million in Runway Growth shares valued at closing NAV per share and approximately $145 million in cash.
- The cash payment will be based on SWK’s final NAV, which will be struck 48 hours prior to closing and reflective of SWK’s accumulated retained earnings between June 30, 2025, and close.
- Additionally, Runway Growth Capital, in its capacity as Runway Growth’s external investment adviser, will be contributing $9 million in cash for distribution as consideration to the stockholders of SWK separate from and in addition to the consideration described in the first sentence of this paragraph.
- SWK’s portfolio includes 22 companies, with an approximate fair value of $242 million based on Runway Growth’s estimates conducted as of August 15, 2025.
- The transaction is expected to close in late 2025 or the first quarter of 2026, pending SWK shareholder and regulatory approvals and other customary closing conditions.
- SWKH closed -0.34% at $14.4.
- Source: Press Release
More on SWK Holdings, Runway Growth Finance
- SWK Holdings: High Yielding Debt To Mature Soon, Shares Worth A Buy
- Runway Growth Finance: 14% Dividend Yield At A 25% Discount To NAV
- SWK Holdings signals ongoing capital returns and streamlined focus following major asset sales
- Runway Growth Finance declares $0.33 dividend
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。